Mortality Rate for Acromegaly
Acromegaly is a rare endocrine disorder caused by an overproduction of growth hormone from the pituitary gland. It is typically caused by a benign tumor of the pituitary gland or, less commonly, a tumor of the pancreas or lung. Acromegaly is associated with a number of serious health complications, including an increased risk of mortality.
The mortality rate for acromegaly can vary depending on the severity of the condition, as well as other factors such as age, gender, and the presence of other comorbidities. Studies have found that the mortality rate for acromegaly is higher than the general population, with estimates ranging from 1.5 to 3.3 times higher than the general population. The risk of mortality is higher in individuals with more severe acromegaly and those with comorbidities such as diabetes and cardiovascular disease.
Early diagnosis and treatment are key to reducing the mortality rate for acromegaly. Treatment typically involves medication, surgery, and/or radiation therapy, depending on the type and severity of the condition. Appropriate treatment can reduce the mortality rate to that of the general population.
It is important to note that the mortality rate for acromegaly is not the same for all individuals. It is important for individuals with acromegaly to speak to their doctor to discuss the best treatment options for their particular condition.